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Advances in the treatment of malignant 
large-bowel obstruction
Most cases of large-bowel obstruction are due to colonic adeno- 
carcinoma.
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Colonic adenocarcinoma accounts for the great majority of cases 
of large-bowel obstruction, and this potentially lethal condition 
presents a difficult management problem for the attending doctor. 
Unrelieved colonic obstruction from any cause leads to a 
predictable series of sequelae. Large amounts of fluid and 
electrolytes (especially sodium and potassium) can accumulate 
within the bowel, leading to intravascular depletion and shock. 
As the bowel distends, increasing pressure may lead to mucosal 
ischaemia, which can cause the barrier function of the mucosa to 
fail, resulting in translocation of bacteria into the bloodstream and 
systemic sepsis. As congestion and impaired perfusion of the gut 
wall worsen, transmural ischaemia may develop, ultimately leading 
to perforation and faeculent peritonitis. Once perforation occurs, 
the prognosis worsens considerably, with mortality rates around 30 
- 40% typically being quoted. 
The immediate priorities in the treatment of colonic obstruction 
are therefore fluid resuscitation and relief of the obstruction, with 
resection of the tumour and restoration of intestinal continuity (if 
possible) being important but not urgent goals of treatment. 
Left versus right-sided colonic 
obstruction 
Obstructing lesions of the left (distal) side of the colon present 
the surgeon with a more complex problem than lesions of the 
right (proximal) side. The standard operation for an obstructing 
lesion of the ascending colon would be a right hemicolectomy 
and primary anastomosis. This is a relatively small and technically 
straightforward operation, and an anastomosis between normal 
terminal ileum and normal, collapsed colon downstream of the 
resected bowel can be performed, which carries a low risk of 
breakdown and leakage.
In contrast, resections of left-sided colonic lesions are more difficult, 
and one is faced with the decision of whether to do an anastomosis 
using abnormal, dilated colon containing large amount of faeces in 
a patient who may be in a poor general condition. Concerns about 
the possibility of anastomotic leakage in this setting, and attempts 
to diminish this risk, have led to a number of surgical strategies 
for this problem. Until recently, the available options all involved 
operations, described as one-, two- or three-stage surgery.1
Three-stage surgery
Until the 1970s there was broad agreement that this was the only 
safe approach to left-sided colonic obstruction. At the initial 
operation, a loop colostomy is fashioned proximal to the obstructing 
tumour (which is left in situ) in order to decompress the bowel. 
This is a small, quick operation that in extremely ill patients may 
even be performed under local anaesthetic, and deals with the 
immediately life-threatening problem. Some time later, once the 
patient’s general condition has been optimised, a second operation 
is performed to resect the tumour, and an anastomosis is done. The 
previously fashioned colostomy serves to divert the faecal stream 
proximal to the anastomosis. The final-stage operation, undertaken 
a few months later, is to close the stoma. The disadvantages of this 
approach were that the patients required repeated surgery, all had 
stomas and a significant proportion (about 25%) never had their 
stoma closed.
Two-stage surgery
Later it became increasingly common for surgeons to perform 
a resection of the tumour, oversewing the rectal stump, and 
fashioning an end colostomy (Hartmann’s procedure) as the initial 
operation. The patient could then be brought back to theatre at a 
later date to close the stoma. This led to shorter hospital stays than 
the three-stage procedure, but possibly even more patients (up to 
60% in some series) never had their stoma closed. 
Unrelieved colonic 
obstruction from any cause 
leads to a predictable series 
of sequelae.  
The immediate priorities 
in the treatment of colonic 
obstruction are therefore 
fluid resuscitation and relief 
of the obstruction.
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One-stage surgery
It recently began to be widely accepted 
that resection of the tumour and primary 
anastomosis could safely be performed on 
obstructed bowel. The obvious advantages 
of this approach are that the patient is 
spared a stoma, and needs to undergo only 
one operation. There are two commonly 
employed strategies for this approach: 
either segmental resection of the bowel 
containing the tumour followed by on-
table lavage of the upstream bowel prior to 
anastomosis; or else a subtotal colectomy 
is performed (in other words the tumour 
and all colon proximal to it is resected), 
and the terminal ileum is anastomosed 
to the colon or rectum downstream 
of the tumour. One randomised trial 
has compared these two approaches,2 
and found them to be equivalently 
safe, but that long-term bowel function 
was worse in the subtotal colectomy 
group. There are circumstances where 
a subtotal colectomy may be preferred, 
such as in more proximal tumours, 
and in patients where there is a higher 
chance of synchronous or metachronous 
tumours (such as young patients or 
those with a strong family history). More 
recently, the necessity of on-table lavage 
(a time-consuming procedure which, if 
done incorrectly, can lead to disastrous 
peritoneal soiling with faeces) has been 
questioned, with simple decompression 
of the bowel prior to anastomosis being 
advocated. There is probably little to 
choose between these options, but it 
is important to understand that all are 
technically extremely demanding even 
for  experienced  colorectal surgeons, and 
are major operations to embark upon in a 
haemodynamically unstable, sick patient.
Stenting of left-sided 
colonic lesions
Perhaps the most significant recent 
advance in emergency colorectal surgery 
has been the advent of self-expanding 
metal stents, which allow non-operative 
decompression of obstructing lesions. 
These are similar in design to biliary, 
vascular and other types of stent. They are 
essentially wire mesh tubes, constructed 
in such a way that they can be deployed 
through a narrow lumen, and then slowly 
expand. They are used in two settings – to 
provide palliation in incurable patients, 
and as a ‘bridge to surgery’ in those with 
potentially resectable disease.
Palliative stenting
About 25% of patients with obstructing 
colonic malignancies will have incurable 
metastatic disease at the time of 
presentation.3 In this group of patients, 
the goal of therapy is to relieve their 
obstruction in order to palliate this 
extremely painful symptom, ideally in as 
non-invasive a way as possible. Colonic 
stenting offers palliation that is effective 
in about 90% of cases, and durable, 
with the majority of patients remaining 
unobstructed until death from metastatic 
disease.4,5 The advantages of this approach 
are that the patient avoids an operation, 
which in this setting carries significant 
morbidity and mortality, and can avoid a 
stoma.
‘Bridge to surgery’
Patients with curable malignant 
obstruction may also benefit from stenting. 
In this setting, emergency stenting allows 
the patient to have his bowel decompressed 
quickly, after which an elective colonic 
resection with primary anastomosis may 
be more easily and safely done once the 
patient’s fluid and nutritional status have 
been improved, and the operation can be 
done on undilated bowel. It is also worth 
bearing in mind that often we do not 
know for sure if metastases are present at 
the initial emergency presentation, and 
stenting allows time for accurate staging 
to be done. A number of these patients are 
then found to have incurable disease, and 
the stent becomes the definitive palliative 
procedure.
Safety
The very best single institution mortality 
rate for emergency surgery for colonic 
obstruction is 3%,6 but this is not typical 
of most surgeons’ experience worldwide, 
with mortality rates around 10 - 25%7,8 
reported in various series.
Put into this perspective, colonic stenting 
has been found to be remarkably safe. In a 
large systematic review of 29 case series4 
there were a total of 3 deaths out of 598 
patients undergoing stenting (< 1%). Two 
of these patients died after perforation of 
the bowel during stent insertion, which is 
the most dangerous complication of this 
procedure. Among the large published 
series of colonic stenting, the mean rate 
of bowel perforation is 4%, with a range 
of 0 - 16%.4 The other rarer reported 
complications include tenesmus and anal 
pain in patients with rectal stents. A meta-
analysis of studies (most non- randomised) 
comparing stenting with surgery for 
malignant large-bowel obstruction9 found 
a significantly lower mortality rate, fewer 
complications, and shorter hospital stay in 
the stented group, even though in many 
cases the sicker patients were probably the 
ones selected for stenting. 
Technique
Once malignant large-bowel obstruction 
is suspected clinically and on plain X-rays 
(Fig.1), the diagnosis should be confirmed, 
and the level of obstruction identified, 
using a single contrast enema (Fig. 2), 
contrasted CT scan or flexible endoscopy. 
Where contrast is used, if one is considering 
stenting as therapy, it is important to use a 
water-soluble contrast rather than barium, 
as the latter is not easily cleaned out of 
the bowel, and can significantly impair 
endoscopic visualisation of the lesion.
 About 25% of patients with obstructing 
colonic malignancies will have 
incurable metastatic disease at the 
time of presentation.
It is important to use a water-soluble 
contrast rather than barium, as the 
latter is not easily cleaned out of the 
bowel, and can significantly impair 
endoscopic visualisation of the lesion.
Fig. 1. The typical X-ray appearance of 
large-bowel obstruction.
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A colonoscope is introduced into the 
bowel via the anus, and the obstructing 
tumour visualised by the endoscopist. 
A guidewire (Fig. 3) is passed down the 
scope and through the narrowed lumen of 
the bowel, and a catheter passed over the 
wire. Contrast is then injected through the 
catheter in order to confirm its position 
within the lumen of the bowel, and to 
identify the upper limit of the tumour. The 
stent is then railroaded over the guidewire 
across the lesion (Fig. 4) and deployed 
using a specialised delivery system. This is 
all done under radiological screening.
Once in situ, it slowly expands, creating a 
1- 2 cm lumen. If successful, decompression 
is usually rapid and dramatic, with almost 
immediate relief of symptoms (Fig. 5). 
Which procedure is most 
appropriate?
There seems to be little doubt that stenting 
is the treatment of choice in the palliative 
setting, as it offers the patient minimally 
invasive and durable palliation without a 
stoma, with as little time as possible spent 
in hospital and recovering from surgery. It 
is also a cost-effective form of treatment 
– although the stents themselves are 
expensive (several thousand rands), this 
is considerably less than the cost of an 
operation. 
In the ‘bridge to surgery’ group of patients, 
the advantages of stenting are less clear, 
as the patient will ultimately require 
surgery. A multicentre randomised trial is 
currently attempting to clarify this issue, 
but on current evidence, stenting appears 
to be the best way of allowing later one-
stage surgery to be done safely. 
Indeed, we would argue that colonic 
stenting should be the first-line treatment 
of left-sided malignant colonic obstruction, 
with surgery reserved for those patients 
where there is clinical suspicion of bowel 
infarction or perforation (evidenced by 
peritonitis, acidosis or signs of sepsis) or 
where stent placement is unsuccessful. 
This has become the standard approach at 
our institution.
While colonic stenting and single-stage 
surgery without stoma formation may 
be regarded as the ideal standard of care 
in malignant colonic obstruction, one 
must take into consideration the available 
surgical expertise when recommending an 
appropriate treatment strategy for these 
patients. Stenting is not widely available in 
South Africa, requiring radiological and 
endoscopic equipment, and specialised 
skills to perform the procedure, and few 
centres see these patients in sufficient 
numbers to allow these skills to be readily 
acquired. 
Similarly, single-stage emergency surgery 
for colonic obstruction is not always 
appropriate. In South Africa, a large amount 
of emergency surgery is, by necessity, 
performed by medical officers without 
advanced surgical training. In this situation 
we believe it would be unwise to advocate 
the single-stage operations, which are 
technically demanding, time-consuming, 
and carry the risk of anastomotic leaks. 
It is probably safest, if one has limited 
colorectal surgical experience or the 
patient is haemodynamically unwell, 
simply to bring out a diverting colostomy 
and refer the patient to a specialised 
centre for definitive surgery. Although 
the treatment of malignant colonic 
obstruction has advanced over the years, 
the logic of the old three-stage procedure 
still stands. It should also be stressed 
that decompression of obstructed bowel 
by whatever means, and not resection of 
the tumour, is the urgent and life-saving 
surgical priority.
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Fig. 2. The gastrograffin enema of the same 
patient, showing obstruction at the level of 
the proximal sigmoid colon.
Fig. 3. A guidewire being introduced through 
an obstructing lesion (the lumen is about  
2 mm in diameter).
Fig. 4. The stent is placed through the le-
sion, railroaded over the guidewire.
Fig. 5. The stent has been deployed. Note 
the hourglass shape of the stent, with the 
neck across the lesion, and the colon has 
markedly decompressed. 
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In a nutshell 
•    Malignant colonic obstruction carries a 
high mortality rate.
•    The priorities of treatment are fluid re-
suscitation and decompression of the 
upstream bowel.
•    Right-sided obstructing lesions are usu-
ally treated by a right hemicolectomy 
and primary anastomosis.
•    Colonic stenting offers a safe, minimally 
invasive approach to decompressing the 
obstructed colon.
•    Colonic stenting may be done as de-
finitive palliation, or as a 'bridge to sur-
gery'.
•    Several operative strategies exist for 
left-sided colonic obstruction, and the 
choice of procedure depends on the 
general condition of the patient, and the 
surgeon's experience.
•    In an unstable patient, or when the sur-
geon is inexperienced in major colonic 
surgery, a defunctioning colostomy is a 
safe option for emergency decompres-
sion of the bowel.
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